ArticleBMC microbiology2025
Effects of dietary supplementation with Bacillus coagulans on growth and immune performance, rumen microorganisms, and metabolites of yaks.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multi-omics reveals effects of several rumen bacteria on reproductive performance of sheep.Microbiome · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The role of probiotics in improving animal growth performance and immune function is increasingly recognized. However, their effects on the growth performance, immune function, rumen microbiota and metabolites of yak in China's high-altitude regions remain unclear. In this study, 20 two-year-old yaks of similar body weight were randomly divided into two groups, with 10 animals in each group. One group served as the control group (CG) and was fed a basal diet, while the other group was fed a basal diet supplemented with 1 g/kg of Bacillus coagulans (live bacteria count ≥ 5 × 10⁹ CFU/kg) as the experimental group (CP) for 60 days. The supplementation of probiotics resulted in a 20.6% increase in body weight in the CP group, which was 5.5% higher than that in the CG group, and the feed-to-gain ratio in the CP group was 2.42 lower than that in the CG group. Additionally, compared with the CG group, the levels of IgM, IgA, IgG, IL-10, IGF-1, GH, and NOS were significantly increased in the CP group (p < 0.05). Notably, the addition of Bacillus coagulans led to a significant increase in beneficial bacteria such as Prevotella and Roseburia in the rumen of the CP group, while pathogenic bacteria such as Treponema were significantly reduced. This may have regulated metabolic pathways involving amino acids and promoted the production of immune and growth-related metabolites such as Ile-Leu-Thr and Glu-Gly-Ser, ultimately enhancing the immune function and growth performance of yak. Overall, these results are encouraging, suggesting that probiotics may serve as an effective alternative to antibiotic growth promoters for improving yak growth performance and intestinal health.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.